CRN is open to meet with Sen. McCaskill about cognitive supplements
CRN’s Day on the Hill also was well-timed to address Sen. Claire McCaskill’s inquiry into what regulators and retailers are doing to prevent the sales of products that claim to treat dementia, Alzheimer’s disease and improve memory.
“We wanted to make sure that members of Congress … knew that responsible industry welcomes the opportunity to sit with Sen. McCaskill and talk about how supplements are regulated and how adverse event reporting works and to diffuse any anxiety” the inquiry may cause, said Mister, who posed during the day with Rep. Brett Guthrie, R.-Ky., and Rep. Jared Polis, D-Colo.